TY - JOUR
T1 - A case of primary aldosteronism revealed after renal transplantation
AU - Hoorn, Ewout
AU - Hesselink, Dennis
AU - Kho, MM
AU - Roodnat, J.I.
AU - Weimar, Willem
AU - van Saase, JL
AU - van den Meiracker, Ton
AU - Zietse, R.
PY - 2011
Y1 - 2011
N2 - Background. A 57-year-old woman was referred to a nephrology clinic because of chronic hypokalemia. She had a history of polycystic kidney disease, resistant hypertension, atrial fibrillation, type 2 diabetes, stroke, and end-stage renal disease, and had received a kidney transplant from a deceased donor at the age of 48 years. At presentation, the patient described symptoms of chronic fatigue and muscle aches, but she did not report pareses. Her medications included four antihypertensive agents, glucose-lowering drugs, immunosuppressants, digoxin, a coumarin derivative, and potassium chloride. Investigations. Full history, physical examination, laboratory testing of blood and urine, including aldosterone-to-renin ratio, and a saline infusion test. Diagnosis. Primary aldosteronism. Management. Treatment with spironolactone resulted in prompt control of hypertension and hypokalemia, allowing discontinuation of potassium chloride and reduction in antihypertensive medication.
AB - Background. A 57-year-old woman was referred to a nephrology clinic because of chronic hypokalemia. She had a history of polycystic kidney disease, resistant hypertension, atrial fibrillation, type 2 diabetes, stroke, and end-stage renal disease, and had received a kidney transplant from a deceased donor at the age of 48 years. At presentation, the patient described symptoms of chronic fatigue and muscle aches, but she did not report pareses. Her medications included four antihypertensive agents, glucose-lowering drugs, immunosuppressants, digoxin, a coumarin derivative, and potassium chloride. Investigations. Full history, physical examination, laboratory testing of blood and urine, including aldosterone-to-renin ratio, and a saline infusion test. Diagnosis. Primary aldosteronism. Management. Treatment with spironolactone resulted in prompt control of hypertension and hypokalemia, allowing discontinuation of potassium chloride and reduction in antihypertensive medication.
U2 - 10.1038/nrneph.2010.158
DO - 10.1038/nrneph.2010.158
M3 - Article
VL - 7
SP - 55
EP - 60
JO - Nature Reviews Nephrology
JF - Nature Reviews Nephrology
SN - 1759-5061
IS - 1
ER -